ANIP News and Press, ANI Pharmaceuticals Inc. From 07/31/19

BAUDETTE, Minn. , July 31, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2019 financial results on Wednesday, August 7, 2019 , before the opening of the U.S. financial markets. The earni...

Company Thesis ANI Pharmaceuticals' ( ANIP ) cortrophin will likely be the sole generic competitor to Mallinckrodt's ( MNK ) blockbuster H.P. Acthar Gel, besting Assertio Therapeutic s' ( ASRT ) investigative cosyntrophin by a wide margin. The company's 5 key branded launches in the past fis...

ANI Pharmaceuticals (NASDAQ: ANIP ) has launched Ranitidine Capsules, 150mg and 300mg. More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

BAUDETTE, Minn. , June 25, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Ranitidine Capsules, 150mg and 300mg.  The current annual U.S. market for this product is approximately $40 million , according to Iqvia/IMS Health. Art...

BAUDETTE, Minn. , June 20, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received FDA approval of its Prior Approval Supplement for Vancomycin Hydrochloride for Oral Solution USP, 250 mg/5 ml, indicated for the treatment of various infec...

ANI Pharmaceuticals ( ANIP +2.3% ) has acquired a pipeline of seven development stage generic products from Coeptis Pharmaceuticals, Inc. for $2.3M in cash and up to $12M in additional development and commercial milestones. More news on: ANI Pharmaceuticals, Inc., Merger & acquisit...

BAUDETTE, Minn. , June 18, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired a pipeline of seven development stage generic products from Coeptis Pharmaceuticals, Inc. for $2.3 million dollars in cash and up to $12.0 mil...

Welcome to Wall Street Brunch, our preview of stock market events for investors to watch during the upcoming week. You can also catch this article a day early by subscribing to the Stocks to Watch account for Saturday morning delivery. Podcast listener? Subscribe now to receive Wall ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...